| Votrient® approved by UK for advanced renal cell carcinoma - Pharmacy Europe |
|
|
Pharmacy Europe The UK health service has started providing Votrient® (pazopanib) treatment to patients with advanced renal cell carcinoma in England and Wales. The treatment advisory body to the National Health Service (NHS) yesterday issued positive final guidance ... New kidney cancer treatment approved WebMD.Boots.com GlaxoSmithKline's Votrient Approved By UK Health Cost Regulator Wall Street Journal James Whale Fund For Kidney Cancer Welcomes NICE's Approval Of Drug In The |